Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Name: Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
SKU: 2693
Price: 30.00 USD
Availability: InStock

$30.00

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

By Charles B. Nemeroff, MD, PhD

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 38 Supplement No. 1 Tags: adolescents, anxiety-disorders, charles-b-nemeroff, children, corticotropin-releasing-factor, crf-dysregulation, early-life-adversity, mood-disorders, physical-abuse, risk, sexual-abuse

Description

Description

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

By Charles B. Nemeroff, MD, PhD

014-020_otsuk…_Nemeroff.qxd_-1

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Description

Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics

A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Description

Related products

Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics

A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders